
Sign up to save your podcasts
Or


In this episode, Professor Iskandar Idris speaks with Dr. Steven Heymsfield about how anti-obesity medications such as semaglutide and tirzepatide affect lean mass. Weight loss with these drugs can include losses of skeletal muscle and bone alongside fat, and the two discuss why that matters, which patients are most vulnerable, and what can help. They cover how body composition is measured in clinical practice, the role of adequate protein intake and resistance training, and the future of drug therapies designed to protect muscle during weight loss.
About the speakers
Dr. Steven Heymsfield is Boyd Professor Emeritus and former Executive Director of the Pennington Biomedical Research Center at Louisiana State University in Baton Rouge. He is a leading expert in obesity, nutrition, body composition, and energy expenditure, and has served as President of ASPEN, the American Society for Nutrition, and of The Obesity Society.
Professor Iskandar Idris is Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.
Disclaimer
This medical education activity is supported by Regeneron and independently developed by Wiley. The content of these podcasts is intended for healthcare professionals only.
Resources
For more medical education from Wiley, visit https://medicine.focus.wiley.com.
To access the latest Diabetes, Obesity and Metabolism publications, visit https://dom-pubs.onlinelibrary.wiley.com/.
Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.
This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this third and final episode, Dr. George Mallas and Dr. Tomas Walker will focus on the technical and design challenges behind CGM systems.
Overview
00:07 Intro & guest introductions
02:57 What a CGM actually measures
05:05 Reference measurements & regulatory comparison standards
06:34 Underreading in the hyperglycemic range
07:06 Accuracy metrics — MARD and error grids
12:05 Closing messages
This medical education activity is co-developed and supported by MiniMed.
The content of these podcasts is intended for healthcare professionals only.
Speaker - Dr. Tomas Walker is a semi-retired former VP Medical Affairs at Dexcom Inc. He is an accomplished clinician, researcher, and diabetes care expert with a distinguished career spanning nearly three decades. A nurse practitioner for more than 28 years, Dr. Walker is a certified diabetes care and education specialist and holds board certifications in both advanced diabetes management and family practice. He's passionate about patient empowerment and healthcare innovations and has published extensively on diabetes technology.
Speaker - Dr. George Mallas is a data science director in the sensor R&D department of MiniMed, where he manages the team that develops the CGM algorithm, which calculates sensor glucose from sensor signals and generates glycaemic alerts.
For more medical education from Wiley, please visit https://focus.wiley.com/
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/
Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.
This three-part audio podcast series is hosted by Professor Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this second episode, Professor Chantal Mathieu will examine the regulatory gaps in CGM evaluation and the need for greater standardization.
Overview
00:07 Intro & guest introduction
02:10 Gaps in CGM accuracy evaluation
06:42 US vs. Europe regulatory comparison
08:55 Path forward for CGM regulation
11:10 Closing message
This medical education activity is co-developed and supported by MiniMed.
The content of these podcasts is intended for healthcare professionals only.
Speaker - Professor Chantal Mathieu is a physician-scientist and an internationally recognized expert in diabetes and endocrinology. Her basic research focuses on the pathogenesis and prevention of type 1 diabetes, including the immune effects of vitamin D. Her clinical research spans new products and treatment approaches in diabetes, type 1 diabetes screening and prevention, diabetes in pregnancy, new insulins and therapies, novel technologies, and adjunct treatments for type 1 diabetes.
Professor Mathieu coordinates INNODIA, the European clinical trial network for interventions in type 1 diabetes, as well as EDENT1FI, a European project focused on screening for type 1 diabetes. She is also President of the European Diabetes Forum, EUDF. She has supervised 30 doctoral theses and authored or co-authored more than 500 peer-reviewed publications in international journals.
For more medical education from Wiley, please visit https://focus.wiley.com/
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/
Welcome to Wiley's DOM Dialogues Podcast, the podcast series brought to you from the journal, Diabetes, Obesity and Metabolism.
This three-part audio podcast series is hosted by Professor Iskandar Idris - Professor of Diabetes and Metabolic Medicine at the University of Nottingham and Honorary Consultant Physician and Endocrinologist at the University Hospitals of Derby and Burton Foundation Trust.
The focus of this series is Continuous Glucose Monitoring (CGM) and covers key clinical, technical, and regulatory considerations. In this first episode, Professor Tadej Battelino will explore the key clinical and scientific issues surrounding CGM use. The episode will also highlight how clinicians should evaluate the quality and consistency of new CGMs entering the market.
Overview
00:09 Intro & guest introduction
02:34 Main clinical challenges with CGM data
04:46 Evaluating quality/consistency of new CGM systems
05:48 Interpreting comparative evidence between CGM systems
07:29 Role of key opinion leaders / professional bodies
09:26 Closing message & future outlook
This medical education activity is co-developed and supported by MiniMed.
The content of these podcasts is intended for healthcare professionals only.
Speaker - Professor Tadej Battelino is currently Consultant and Head of Department of Endocrinology at UCH-UMC, Ljubljana, a clinical pharmacologist, Head, Chair of Pediatrics, and Professor of Pediatrics at Faculty of Medicine at the University of Ljubljana. His research focuses on diabetes, endocrinology, metabolism, and advanced diabetes technologies. With more than 455 peer-reviewed publications, his work has significantly shaped pediatric diabetes care and innovation. He has received several prestigious honors, including the Slovene national award for research, University of Ljubljana Gold Medal for research, the ISPAD Achievement Award, the European Society for Pediatric Endocrinology (ESPE) Research Award, and an international diabetes leadership award. He also serves as Chair of the International Diabetes Federation Europe and is a member of leading scientific academies and professional societies.
For more medical education from Wiley, please visit https://focus.wiley.com/
Diabetes, Obesity and Metabolism is the only interdisciplinary journal for high-quality research and reviews in the areas of diabetes, obesity and metabolism. To access our latest publications, please visit https://dom-pubs.onlinelibrary.wiley.com/
In this inaugural episode of DOM Dialogues, Editor-in-Chief Professor Richard Donnelly introduces the podcast and explores its purpose in bringing Diabetes, Obesity and Metabolism research to life. Through this opening conversation, he reflects on the journal’s evolution, highlights the need for accessible, real-world insights, and previews the key topics from emerging therapies to evolving clinical guidance, that listeners can expect in future episodes.
From the publisher's feed
DOM Dialogues is the official podcast of the journal, Diabetes, Obesity and Metabolism, published by Wiley. Each episode brings leading experts together for accessible,…